In a letter sent to the capital markets regulator SEBI, the whistle-blower accused that Sun Pharmaceuticals had committed corporate governance and tax-related lapses, apart from other securities market-related violations.
from The Financial ExpressThe Financial Express https://ift.tt/2PfYNlY
Monday, 3 December 2018
Sun Pharma shares crash as much as 11% on reports SEBI may reopen insider trading case
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment